THE OPIOID COLLABORATIVE
THE OPIOID CRISIS IS REAL
There are more than 2.5 million opioid addicts in the US, leading to 64,000 deaths per year... and the number is growing
Over 90% of all patients addicted to opioids will need chronic medication-assisted treatment for the rest of their lives
Effective treatment drastically reduces the cost of total care, lowers crime rates, and boosts family stability
OUR AREAS OF EXPERTISE
OUR AREAS OF EXPERTISE
FIGHTING THE OPIOID EPIDEMIC
In 2015, MHDG partnered with seven leading institutions on the front battle lines of the opioid epidemic to form the Opioid Collaborative, one of the world's first integrated, medically driven solutions to the opioid crisis.
Co-led by MHDG's medical director, one of Washington DC's leading addiction medicine experts, our collective goal is to transform opioid addiction prevention, treatment, and recovery. We became the first such opioid collaboration in operation in the US, with six clinical sites established in Washington, DC by September 2018 and several co-managed sites planned across three states for the next year. (If you're interested in joining these sites, let us know!) These sites are NCQA certified, nationally recognized as centers of both medication-assisted treatment (MAT) training & certification and clinical leadership.
We deliver a patient-centered model based on biopsychosocial coordination of care that recognizes the opioid epidemic first as a medical crisis. Our model integrates MAT, mental health treatment, addiction counseling, chronic disease management, and medical care into a single collaborative solution.
The biopsychosocial approach systematically considers biological, psychological, and social factors and their complex interactions in understanding health, illness, and healthcare delivery.
University of Rochester Medical Center
DIFFERENT THAN WHAT HAS COME BEFORE
Until now, no one else in the marketplace had effectively applied the network effect, combined with technology, to produce quantifiable, measured outcomes. Instead, opioid treatment was fragmented, with silos of mental health, addiction therapy, and clinical care, none of which communicated much if at all with the others. Opioid expertise was almost nonexistent in primary care.
We bring all four areas of expertise together. We also recognize the importance of telehealth in solving care access issues and have fully integrated it into our scheduling and care.
" Opioid treatment will transform the healthcare delivery system as we know it. It is going to shine a bright light on the fragmentation in mental health, addiction treatment, and physical medicine. It will bring to the forefront the longstanding bureaucratic policies that are the barrier to achieving the triple aim."
Larry Gourdine | Chief Engagement Officer, The Opioid Collaborative